Abstract
The placenta occupies a critical place in fetal programming by modulating fetal responses to alterations in the maternal environment, by regulating transfer of nutrients between mother and fetus and by responding to changes in environmental stimuli that affect maternal and/or fetal physiology. Placental size and function are exquisitely sensitive to alterations in maternal nutrition, oxygen tension and exposure to glucocorticoids. These factors affect the activity of proteins such as the System A transporter that shuttles neutral amino acids to the fetus, the activity of cells such as those producing placental lactogen, a key metabolic hormone of pregnancy, and the generation of peptides such as the urocortins, members of the corticotrophin releasing hormone family with pro-and anti-inflammatory activities, and placental 11βhydroxysteroid dehydrogenase-2, which regulates placental metabolism of maternal cortisol. Maternal administration of exogenous synthetic glucocorticoid bypasses this metabolic barrier, programming reductions in fetal body weight and composition, and changing development of the fetal neurologic, pancreatic and hypothalamic-pituitary-adrenal (HPA) axes, leading to altered stress and inflammatory responses, cardiovascular activity and predisposition to insulin resistance in later life. Interestingly, many of these placental functions appear to be regulated in a manner that is dependent upon the sex of the fetus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alexander N, Rosenlocher F, Stalder T, Linke J, Distler W, Morgner J, Kirschbaum C (2012) Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocr Metab 97:3538–3544
Alfaidy N, Gupta S, DeMarko C, Caniggia I, Challis JRG (2002) Oxygen regulation of placental 11β-beta-hydroxysteroid dehydrogenase 2: physiological and pathological implications. J Clin Endocrinol Metab 87:4797–4805
Audette MC, Greenwood SL, Sibley CP, Jones CJ, Challis JRG, Matthews SG, Jones RL (2010) Dexamethasone stimulates placental system A transport and trophoblast differentiation in term villous explants. Placenta 31:97–105
Audette MC, Challis JRG, Jones RL, Sibley CP, Matthews SG (2011) Antenatal dexamethasone treatment in midgestation reduces system A-mediated transport in the late gestation murine placenta. Endocrinology 152:3561–3570
Barker DJ (1994a) The fetal origins of adult disease. Fetal Maternal Rev Med 6:71–80
Barker DJP (1994b) Mothers, babies and disease in later life. BMJ Publishing Group, London, UK, p 180
Begum G, Stevens A, Connor K, Challis JRG, Bloomfield F, White A (2012) Epigenetic changes in fetal hypothalamic energy regulating pathways are associated with maternal undernutrition and twinning. FASEB J 26:1694–1703
Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR (1993) Glucocorticoid exposure in utero: new model for hypertension. Lancet 341:339–341
Bloomfield F, Oliver M, Hawkins P, Campbell M, Phillips D, Breier B, Gluckman P, Challis JRG, Harding J (2003) A periconceptional nutritional origin for non-infectious preterm birth. Science 300:606
Bloomfield FH, Oliver MH, Hawkins P, Holloway AC, Campbell M, Gluckman PD, Harding JE, Challis JRG (2004) Periconceptional undernutrition in sheep accelerates maturation of the fetal hypothalamic-pituitary-adrenal axis in late gestation. Endocrinology 145:4278–4285
Braun T, Li S, Moss TJM, Newnham JP, Challis JRG, Gluckman PD, Sloboda DM (2007) Effects of maternal betamethasone on binucleate cell number and ovine placental lactogen in sheep. J Endocrinol 194:337–347
Braun T, Li S, Sloboda DM, Li W, Audette MC, Moss TJ, Mattews SG, Polgiase G, Nitsos I, Newnham JP, Challis JRG (2009) Effects of maternal dexamethasone treatment in early pregnancy on pituitary-adrenal axis in fetal sheep. Endocrinology 150:5466–5477
Burton GJ, Barker DJP, Moffett A, Thornburg K (2011) The placenta and human developmental programming. Cambridge University Press, Cambridge, UK, p 246
Challis JRG (2012) Endocrine disorders in pregnancy: stress responses in children after maternal glucocorticoids. Nat Rev Endocrinol 8:629–630
Challis JRG, Connor K (2009) Glucocorticoids, 11beta-hydroxysteroid dehydrogenase: mother, fetus or both? Endocrinology 150:1073–1074
Clifton VL (2010) Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta 31(Suppl):S33–S39
Clifton VL, Read MA, Leitch IM, Giles WB, Boura A, Robinson PJ, Smith R (1995) Corticotropin-releasing hormone-induced vasodilation in the human feto-placental circulation:involvement of the nitric oxide-cyclic guanosine 3I5I-monophosphate-mediated pathway. J Clin Endocr Metab 80:288–293
Connor KL, Challis JRG, van Zijl PL, Rumball CW, Alix S, Jaquiery AL, Oliver MH, Harding JE, Bloomfield FH (2009) Do alterations in placental 11 β-hydroxysteroid dehydrogenase (11βHSD) activities explain differences in fetal hypothalamic pituitary adrenal (HPA) function following periconceptional undernutrition or twinning in sheep? Reprod Sci 16:1201–1212
Davis EP, Waffarn F, Uy C, Hobel CJ, Glynn LM, Sandman CA (2009) Effect of prenatal glucocorticoid on size at birth among infants born at term gestation. J Perinatol 29:731–737
Desforges M, Mynett KJ, Greenwood SL, Westwood M, Sibley CP, Glazier JD (2009) The SNAT4 isoform of the system A amino acid transporter is functional in human placental microvillous plasma membrane. J Physiol 587:61–72
Fowden AL, Li J, Forhead AJ (1998) Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance? Proc Nutr Soc 57:113–122
Gatford KL, Owens JA, Li S, Moss TJ, Newnham JP, Challis JRG, Sloboda DM (2008) Repeated betamethasone treatment of pregnant sheep programs persistent reduction in circulating IGF-I and IGF-binding proteins in progeny. Am J Physiol Endocrinol Metab 295:E170–E178
Glazier JD, Cetin I, Perugino G, Ronzoni S, Grey AM, Mahendran D, Marconi AM, Pardi G, Sibley CP (1997) Association between the activity of system A amino acid transporter in the microvillous plasma membrane of the human placenta and severity of fetal compromise in intrauterine growth restriction. Pediatr Res 42:514–519
Gluckman PD, Hanson M (2006) Mismatch: why our world no longer fits our bodies. Oxford University Press, Oxford, UK, p 285
Gluckman PD, Hanson M, Zimmet P, Forrester T (2011) Losing the war against obesity: the need for a developmental perspective. Sci Translational Med 3:17–19
Ikegami M, Jobe AH, Newnham J, Polk DH, Willett KE, Sly P (1997) Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Resp Crit Care Med 156:178–184
Imperatore A, Florio P, Torres EB, Torricelli M, Galleri L, Toti P, Occhini R, Picciolini E, Vale W, Petraglia F (2006) Urocortin2 and urocortin 3 are expressed by the human placenta, deciduas and fetal membranes. Am J Obstet Gynecol 195:288–295
Imperatore A, Li W, Petraglia F, Challis JR (2009) Urocortin 2 stimulates estradiol secretion from cultured human placental cells; an effect mediated by the type 2 corticotrophin-releasing hormone (CRH) receptor. Reprod Sci 16:551–558
Imperatore A, Rolfo A, Petraglia F, Challis JR, Caniggia I (2010) Hypoxia and preeclampsia: increased expression of Urocortin 2 and Urocortin 3. Reprod Sci 9:833–843
Jaquiery AL, Oliver MH, Honeyfield-Ross M, Harding JE, Bloomfield FH (2012) Periconceptional undernutrition in sheep affects adult phenotype only in males. J Nutr Med 2012:123610
Jansson T, Powell TL (2006) Human placental transport in altered fetal growth: does the placenta function as a nutrient sensor: a review. Placenta 27(Suppl A), Trophoblast Res 20:S91–S97
Jones HH, Powell TL, Jansson T (2007) Regulation of placental transport-a review. Placenta 28:763–774
Langley-Evans SC, Gardner DS, Jackson AA (1996) Association of disproportionate growth of fetal rats in late gestation with raised systolic blood pressure in later life. J Reprod Fertil 106:307–312
Li S, Sloboda DM, Moss TJM, Nitsos I, Polglase GR, Doherty DA, Newnham JP, Challis JRG, Braun T (2013) Effects of glucocorticoid treatment given in early or late gestation on growth and development in sheep. J DOHaD 4:146–156
Liggins GC, Howie RN (1972) A controlled trail of antpartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50:515–525
Mahendran D, Donnai P, Glazier JD, D'Souza SW, Boyd RD, Sibley CP (2003) Amino acid (system A) transporter activity in microvillous membrane vesicles from the placentas of appropriate and small for gestational age babies. Pediatr Res 34:661–665
Matthews SG, Owen D, Banjanin S, Andrews MH (2002) Glucocorticoids, hypothalamo-pituitary-adrenal (HPA) development, and life after birth. Endocr Rev 28:709–718
McKinlay CJ, Crowther CA, Middleton P, Harding JE (2012) Repeat antenatal corticosteroids for women at risk of preterm birth. Am J Obstet Gynecol 206:187–194
Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JRG, Newnham JP (2001) Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol 281:R960–R970
Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN, Matthews SG, Saigal S, Asztalos E, Ross S, Delisle M-F, Amankwah K, Guselle P, Gafni A, Lee SK, Armson BA (2008) Multiple courses of antnatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet 372:2143–2151
Murphy VE, Smith R, Giles WB, Clifton VL (2006) Endocrine regulation of human fetal growth: the role of the mother, placenta and fetus. Endocr Rev 27:141–169
Newnham JP, Jobe AH (2009) Should we be prescribing repeated courses of antenatal corticosteroids? Sem Fetal Neonatal Med 14:157–163
Newnham JP, Pennell CE, Lye SJ, Pampono J, Challis JRG (2009) Early life origins of obesity. Obstet Gynecol Clin North Am 36:227–244
Petraglia F, Florio P, Nappi C, Genazzani AR (1996) Peptide signalling in the placenta and membranes: autocrine, paracrine and endocrine mechanisms. Endocr Rev 17:156–186
Petraglia F, Imperatore A, Challis JRG (2010) Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 31:783–816
Rumball CWH, Harding JE, Oliver MH, Bloomfield FH (2008) Effects of twin pregnancy and periconceptional undernutrition on maternal metabolism, fetal growth and glucose-insulin axis function in ovine pregnancy. J Physiol 586:1399–1411
Seckl JR (1997) Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 62:89–94
Sirianni R, Mayhew BA, Carr BR, Parker CR Jr, Rainey WE (2005) Corticotropin-releasing hormone (CRH) and urocortin act through Type1 CRH receptors to stimulate dehydroepiandrosterone sulfate production in human fetal adrenal cells. J Clin Endocr Metab 90:5393–5400
Sloboda D, Newnham J, Challis J (2000) Effects of repeated maternal betamethasone administration on growth and HPA function of the ovine fetus at term. J Endocrinol 165:79–91
Sloboda DM, Challis JRG, Moss TJM, Newnham JP (2005) Synthetic glucocorticoids: antenatal administration and long-term implications. Curr Pharmaceut Design 11:1459–1472
Sloboda D, Moss T, Li S, Doherty D, Nitsos I, Challis JRG, Newnham J (2006) Prenatal betamethasone exposure results in pituitary-adrenal hypo-responsiveness in adult sheep. Am J Physiol Endocrinol Metab 292:61–70
Stevens A, Begum G, Cook A, Connor K, Rumball C, Oliver M, Challis JRG, Bloomfield F, White A (2010) Epigenetic changes in the hypothalamic proopiomelanocortin and glucocorticoid receptor genes in the ovine fetus after periconceptional undernutrition. Endocrinology 151:3652–3664
Thompson NM, Norman AM, Donkin SS, Shankar RR, Vickers MH, Miles JL, Breier BH (2007) Prenatal and postnatal pathways to obesity: different underlying mechanisms, different metabolic outcomes. Endocrinology 148:2345–2354
Torricelli M, Novembri R, Bloise E, DeBonis M, Challis J, Petraglia F (2011) Changes in placental CRH, urocortins and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis. J Clin Endocr Metab 96:534–540
Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD (2000) Fetal origins of hyperphagia, obesity and hypertension and its post natal amplification by hypercaloric nutrition. Am J Physiol 279:E83–E87
Vickers MH, Cupido C-L, Gluckman PD (2007) Developmental programming of obesity and type 2 diabetes. Fetal Maternal Med Rev 18:1–23
Wyrwoll CS, Seckl JR, Holmes MC (2009) Altered placental function of 11β-hydroxysteroid dehydrogenase-2 knockout mice. Endocrinology 150:1287–1293
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Challis, J. et al. (2014). The Role of the Placenta in Fetal Programming. In: Seckl, J., Christen, Y. (eds) Hormones, Intrauterine Health and Programming. Research and Perspectives in Endocrine Interactions, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-02591-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-319-02591-9_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-02590-2
Online ISBN: 978-3-319-02591-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)